Showing 51-60 of 8597 results for "".
Revisiting Cyclosporine in the Age of Biologics: Update on Efficacy and Mechanism of Action
https://practicaldermatology.com/topics/general-topics/revisiting-cyclosporine-in-the-age-of-biologics-update-on-efficacy-and-mechanism-of-action/21937/Increased understanding of the immunologic basis of psoriasis supports the role of cyclosporine in patient management.Fine Particulate Matter and Eczema
https://practicaldermatology.com/issues/july-2025/fine-particulate-matter-and-eczema/36512/The primary objective of this study was to investigate the potential associations between fine particulate matter (specifically PM2.5) exposure and eczema. Researchers on this study set out to explore whether the odds of having eczema would increase with greater PM2.5 exposure, and to identify whethThe Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.Maximizing Valuation and Outcomes for Practice Owners: A Conversation with Dana Jacoby
https://practicaldermatology.com/topics/practice-management/maximizing-valuation-and-outcomes-for-practice-owners-a-conversation-with-dana-jacoby/29889/Contributor Clint Bundy recently interviewed Dana Jacoby, President and CEO of Vector Medical Group, an operational and strategic consulting firm focused on the healthcare sector, to discuss building value in a dermatology and aesthetics practice and optimal ways to achieve full value for that businTaking a More Holistic View of the Pathogenesis of Acne
https://practicaldermatology.com/topics/acne-rosacea/taking-more-holistic-view-pathogenesis-acne/26539/Taking a More Holistic View of the Pathogenesis of AcneLook to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.Cutaneous Metastasis of Adenocarcinoma with an Unknown Primary Tumor
https://practicaldermatology.com/youngmd-connect/resident-resource-center/cutaneous-metastasis-of-adenocarcinoma-with-an-unknown-primary-tumor/20352/Report and discussion: Cutaneous metastasis of adenocarcinoma with an unknown primary tumor.The Microbiome and Its Impact on Antibiotic Use in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-microbiome-and-its-impact-on-antibiotic-use-in-dermatology/23278/Despite focus on the clinical consequences of overusing antibiotics for decades, relatively little has been said about the potential impact on the microbiome.Psoriasis, Biologics, and Cardiovascular Disease: The Heart of the Matter
https://practicaldermatology.com/topics/psoriasis/psoriasis-biologics-and-cardiovascular-disease-the-heart-of-the-matter/23215/A relationship between increased cardiovascular events in patients with psoriasis has implications for management of this chronic disease.New Rosacea Classification System Encourages
More Precise Assessment and Treatmenthttps://practicaldermatology.com/topics/practice-management/new-rosacea-classification-system-encourages-br-more-precise-assessment-and-treatment/20484/A look at the rationale behind the new classification system and what it means for clinicians.